FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605154961> ?p ?o ?g. }

• W2605154961 endingPage "1743" @default.
• W2605154961 startingPage "1736" @default.
• W2605154961 abstract "Objective: To report the presentation, main syndromes, human leukocyte antigen (HLA) association, and immunoglobulin G (IgG) subclass in the anti-IgLON5 disease: a disorder with parasomnias, sleep apnea, and IgLON5 antibodies. Methods: This was a retrospective clinical analysis of 22 patients. The IgG subclass was determined using reported techniques. Results: Patients' median age was 64 years (range 46–83). Symptoms that led to initial consultation included sleep problems (8 patients; 36%), gait abnormalities (8; 36%), bulbar dysfunction (3; 14%), chorea (2; 9%), and cognitive decline (1; 5%). By the time of diagnosis of the disorder, 4 syndromes were identified: (1) a sleep disorder with parasomnia and sleep breathing difficulty in 8 (36%) patients; (2) a bulbar syndrome including dysphagia, sialorrhea, stridor, or acute respiratory insufficiency in 6 (27%); (3) a syndrome resembling progressive supranuclear palsy (PSP-like) in 5 (23%); and (4) cognitive decline with or without chorea in 3 (14%). All patients eventually developed parasomnia, sleep apnea, insomnia, or excessive daytime sleepiness. HLA-DRB1*10:01 and HLA-DQB1*05:01 were positive in 13/15 (87%) patients; the DRB1*10:01 allele was 36 times more prevalent than in the general population. Among 16 patients with paired serum and CSF samples, 14 had IgLON5 antibodies in both, and 2 only in serum (both had a PSP-like syndrome). Twenty of 21 patients had IgG1 and IgG4 antibodies; the latter predominated in 16. Conclusions: Patients with IgLON5 antibodies develop a characteristic sleep disorder preceded or accompanied by bulbar symptoms, gait abnormalities, oculomotor problems, and, less frequently, cognitive decline. IgG4 subclass antibodies predominate over IgG1; we confirm a strong association with the HLA-DRB1*10:01 allele." @default.
• W2605154961 created "2017-04-14" @default.
• W2605154961 creator A5003461044 @default.
• W2605154961 creator A5003889865 @default.
• W2605154961 creator A5005476543 @default.
• W2605154961 creator A5011954252 @default.
• W2605154961 creator A5014230128 @default.
• W2605154961 creator A5014342106 @default.
• W2605154961 creator A5015721189 @default.
• W2605154961 creator A5016234109 @default.
• W2605154961 creator A5016908006 @default.
• W2605154961 creator A5021324125 @default.
• W2605154961 creator A5029679895 @default.
• W2605154961 creator A5030636571 @default.
• W2605154961 creator A5037217540 @default.
• W2605154961 creator A5042577463 @default.
• W2605154961 creator A5056046035 @default.
• W2605154961 creator A5060587778 @default.
• W2605154961 creator A5070132070 @default.
• W2605154961 creator A5074366850 @default.
• W2605154961 creator A5075410889 @default.
• W2605154961 creator A5076156979 @default.
• W2605154961 creator A5083474896 @default.
• W2605154961 creator A5085451108 @default.
• W2605154961 creator A5089067055 @default.
• W2605154961 creator A5077451032 @default.
• W2605154961 date "2017-04-05" @default.
• W2605154961 modified "2023-10-17" @default.
• W2605154961 title "Clinical manifestations of the anti-IgLON5 disease" @default.
• W2605154961 cites W1969661146 @default.
• W2605154961 cites W1983997527 @default.
• W2605154961 cites W1990640976 @default.
• W2605154961 cites W1998978956 @default.
• W2605154961 cites W2000492706 @default.
• W2605154961 cites W2008134500 @default.
• W2605154961 cites W2014556895 @default.
• W2605154961 cites W2065016560 @default.
• W2605154961 cites W2065363897 @default.
• W2605154961 cites W2096209562 @default.
• W2605154961 cites W2101252880 @default.
• W2605154961 cites W2104829838 @default.
• W2605154961 cites W2136557657 @default.
• W2605154961 cites W2156821098 @default.
• W2605154961 cites W2200775787 @default.
• W2605154961 cites W2285752330 @default.
• W2605154961 cites W2325451877 @default.
• W2605154961 cites W2473655507 @default.
• W2605154961 cites W2514674077 @default.
• W2605154961 cites W2614974832 @default.
• W2605154961 doi "https://doi.org/10.1212/wnl.0000000000003887" @default.
• W2605154961 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5409845" @default.
• W2605154961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28381508" @default.
• W2605154961 hasPublicationYear "2017" @default.
• W2605154961 type Work @default.
• W2605154961 sameAs 2605154961 @default.
• W2605154961 citedByCount "256" @default.
• W2605154961 countsByYear W26051549612017 @default.
• W2605154961 countsByYear W26051549612018 @default.
• W2605154961 countsByYear W26051549612019 @default.
• W2605154961 countsByYear W26051549612020 @default.
• W2605154961 countsByYear W26051549612021 @default.
• W2605154961 countsByYear W26051549612022 @default.
• W2605154961 countsByYear W26051549612023 @default.
• W2605154961 crossrefType "journal-article" @default.
• W2605154961 hasAuthorship W2605154961A5003461044 @default.
• W2605154961 hasAuthorship W2605154961A5003889865 @default.
• W2605154961 hasAuthorship W2605154961A5005476543 @default.
• W2605154961 hasAuthorship W2605154961A5011954252 @default.
• W2605154961 hasAuthorship W2605154961A5014230128 @default.
• W2605154961 hasAuthorship W2605154961A5014342106 @default.
• W2605154961 hasAuthorship W2605154961A5015721189 @default.
• W2605154961 hasAuthorship W2605154961A5016234109 @default.
• W2605154961 hasAuthorship W2605154961A5016908006 @default.
• W2605154961 hasAuthorship W2605154961A5021324125 @default.
• W2605154961 hasAuthorship W2605154961A5029679895 @default.
• W2605154961 hasAuthorship W2605154961A5030636571 @default.
• W2605154961 hasAuthorship W2605154961A5037217540 @default.
• W2605154961 hasAuthorship W2605154961A5042577463 @default.
• W2605154961 hasAuthorship W2605154961A5056046035 @default.
• W2605154961 hasAuthorship W2605154961A5060587778 @default.
• W2605154961 hasAuthorship W2605154961A5070132070 @default.
• W2605154961 hasAuthorship W2605154961A5074366850 @default.
• W2605154961 hasAuthorship W2605154961A5075410889 @default.
• W2605154961 hasAuthorship W2605154961A5076156979 @default.
• W2605154961 hasAuthorship W2605154961A5077451032 @default.
• W2605154961 hasAuthorship W2605154961A5083474896 @default.
• W2605154961 hasAuthorship W2605154961A5085451108 @default.
• W2605154961 hasAuthorship W2605154961A5089067055 @default.
• W2605154961 hasBestOaLocation W26051549612 @default.
• W2605154961 hasConcept C105922876 @default.
• W2605154961 hasConcept C118552586 @default.
• W2605154961 hasConcept C126322002 @default.
• W2605154961 hasConcept C1513209611 @default.
• W2605154961 hasConcept C187212893 @default.
• W2605154961 hasConcept C2777935920 @default.
• W2605154961 hasConcept C2778205975 @default.
• W2605154961 hasConcept C2778868616 @default.
• W2605154961 hasConcept C2779134260 @default.

• next